1 Market Overview of Cancer Genome Sequencing 1.1 Cancer Genome Sequencing Market Overview 1.1.1 Cancer Genome Sequencing Product Scope 1.1.2 Cancer Genome Sequencing Market Status and Outlook 1.2 Global Cancer Genome Sequencing Market Size Overview by Region 2016 VS 2021VS 2027 1.3 Global Cancer Genome Sequencing Market Size by Region (2016-2027) 1.4 Global Cancer Genome Sequencing Historic Market Size by Region (2016-2021) 1.5 Global Cancer Genome Sequencing Market Size Forecast by Region (2022-2027) 1.6 Key Regions, Cancer Genome Sequencing Market Size (2016-2027) 1.6.1 North America Cancer Genome Sequencing Market Size (2016-2027) 1.6.2 Europe Cancer Genome Sequencing Market Size (2016-2027) 1.6.3 Asia-Pacific Cancer Genome Sequencing Market Size (2016-2027) 1.6.4 Latin America Cancer Genome Sequencing Market Size (2016-2027) 1.6.5 Middle East & Africa Cancer Genome Sequencing Market Size (2016-2027) 2 Cancer Genome Sequencing Market Overview by Type 2.1 Global Cancer Genome Sequencing Market Size by Type: 2016 VS 2021 VS 2027 2.2 Global Cancer Genome Sequencing Historic Market Size by Type (2016-2021) 2.3 Global Cancer Genome Sequencing Forecasted Market Size by Type (2022-2027) 2.4 Second Generation 2.5 Third Generation 3 Cancer Genome Sequencing Market Overview by Application 3.1 Global Cancer Genome Sequencing Market Size by Application: 2016 VS 2021 VS 2027 3.2 Global Cancer Genome Sequencing Historic Market Size by Application (2016-2021) 3.3 Global Cancer Genome Sequencing Forecasted Market Size by Application (2022-2027) 3.4 Treatment 3.5 Research 4 Cancer Genome Sequencing Competition Analysis by Players 4.1 Global Cancer Genome Sequencing Market Size by Players (2016-2021) 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cancer Genome Sequencing as of 2020) 4.3 Date of Key Players Enter into Cancer Genome Sequencing Market 4.4 Global Top Players Cancer Genome Sequencing Headquarters and Area Served 4.5 Key Players Cancer Genome Sequencing Product Solution and Service 4.6 Competitive Status 4.6.1 Cancer Genome Sequencing Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data 5.1 Agilent Technologies 5.1.1 Agilent Technologies Profile 5.1.2 Agilent Technologies Main Business 5.1.3 Agilent Technologies Cancer Genome Sequencing Products, Services and Solutions 5.1.4 Agilent Technologies Cancer Genome Sequencing Revenue (US$ Million) & (2016-2021) 5.1.5 Agilent Technologies Recent Developments 5.2 GE Healthcare Life Sciences 5.2.1 GE Healthcare Life Sciences Profile 5.2.2 GE Healthcare Life Sciences Main Business 5.2.3 GE Healthcare Life Sciences Cancer Genome Sequencing Products, Services and Solutions 5.2.4 GE Healthcare Life Sciences Cancer Genome Sequencing Revenue (US$ Million) & (2016-2021) 5.2.5 GE Healthcare Life Sciences Recent Developments 5.3 Johnson & Johnson 5.3.1 Johnson & Johnson Profile 5.3.2 Johnson & Johnson Main Business 5.3.3 Johnson & Johnson Cancer Genome Sequencing Products, Services and Solutions 5.3.4 Johnson & Johnson Cancer Genome Sequencing Revenue (US$ Million) & (2016-2021) 5.3.5 LI-COR Biosciences Recent Developments 5.4 LI-COR Biosciences 5.4.1 LI-COR Biosciences Profile 5.4.2 LI-COR Biosciences Main Business 5.4.3 LI-COR Biosciences Cancer Genome Sequencing Products, Services and Solutions 5.4.4 LI-COR Biosciences Cancer Genome Sequencing Revenue (US$ Million) & (2016-2021) 5.4.5 LI-COR Biosciences Recent Developments 5.5 Abbott Laboratories 5.5.1 Abbott Laboratories Profile 5.5.2 Abbott Laboratories Main Business 5.5.3 Abbott Laboratories Cancer Genome Sequencing Products, Services and Solutions 5.5.4 Abbott Laboratories Cancer Genome Sequencing Revenue (US$ Million) & (2016-2021) 5.5.5 Abbott Laboratories Recent Developments 5.6 Beckman Coulter 5.6.1 Beckman Coulter Profile 5.6.2 Beckman Coulter Main Business 5.6.3 Beckman Coulter Cancer Genome Sequencing Products, Services and Solutions 5.6.4 Beckman Coulter Cancer Genome Sequencing Revenue (US$ Million) & (2016-2021) 5.6.5 Beckman Coulter Recent Developments 5.7 Bayer 5.7.1 Bayer Profile 5.7.2 Bayer Main Business 5.7.3 Bayer Cancer Genome Sequencing Products, Services and Solutions 5.7.4 Bayer Cancer Genome Sequencing Revenue (US$ Million) & (2016-2021) 5.7.5 Bayer Recent Developments 5.8 Hamilton Thorne Biosciences 5.8.1 Hamilton Thorne Biosciences Profile 5.8.2 Hamilton Thorne Biosciences Main Business 5.8.3 Hamilton Thorne Biosciences Cancer Genome Sequencing Products, Services and Solutions 5.8.4 Hamilton Thorne Biosciences Cancer Genome Sequencing Revenue (US$ Million) & (2016-2021) 5.8.5 Hamilton Thorne Biosciences Recent Developments 5.9 Integrated DNA Technologies 5.9.1 Integrated DNA Technologies Profile 5.9.2 Integrated DNA Technologies Main Business 5.9.3 Integrated DNA Technologies Cancer Genome Sequencing Products, Services and Solutions 5.9.4 Integrated DNA Technologies Cancer Genome Sequencing Revenue (US$ Million) & (2016-2021) 5.9.5 Integrated DNA Technologies Recent Developments 5.10 Microchip Biotechnologies 5.10.1 Microchip Biotechnologies Profile 5.10.2 Microchip Biotechnologies Main Business 5.10.3 Microchip Biotechnologies Cancer Genome Sequencing Products, Services and Solutions 5.10.4 Microchip Biotechnologies Cancer Genome Sequencing Revenue (US$ Million) & (2016-2021) 5.10.5 Microchip Biotechnologies Recent Developments 5.11 Myriad Genetics 5.11.1 Myriad Genetics Profile 5.11.2 Myriad Genetics Main Business 5.11.3 Myriad Genetics Cancer Genome Sequencing Products, Services and Solutions 5.11.4 Myriad Genetics Cancer Genome Sequencing Revenue (US$ Million) & (2016-2021) 5.11.5 Myriad Genetics Recent Developments 5.12 Commonwealth Biotechnologies 5.12.1 Commonwealth Biotechnologies Profile 5.12.2 Commonwealth Biotechnologies Main Business 5.12.3 Commonwealth Biotechnologies Cancer Genome Sequencing Products, Services and Solutions 5.12.4 Commonwealth Biotechnologies Cancer Genome Sequencing Revenue (US$ Million) & (2016-2021) 5.12.5 Commonwealth Biotechnologies Recent Developments 5.13 ZS Genetics 5.13.1 ZS Genetics Profile 5.13.2 ZS Genetics Main Business 5.13.3 ZS Genetics Cancer Genome Sequencing Products, Services and Solutions 5.13.4 ZS Genetics Cancer Genome Sequencing Revenue (US$ Million) & (2016-2021) 5.13.5 ZS Genetics Recent Developments 5.14 Pacific Biosciences 5.14.1 Pacific Biosciences Profile 5.14.2 Pacific Biosciences Main Business 5.14.3 Pacific Biosciences Cancer Genome Sequencing Products, Services and Solutions 5.14.4 Pacific Biosciences Cancer Genome Sequencing Revenue (US$ Million) & (2016-2021) 5.14.5 Pacific Biosciences Recent Developments 6 North America 6.1 North America Cancer Genome Sequencing Market Size by Country (2016-2027) 6.2 United States 6.3 Canada 7 Europe 7.1 Europe Cancer Genome Sequencing Market Size by Country (2016-2027) 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific Cancer Genome Sequencing Market Size by Region (2016-2027) 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America Cancer Genome Sequencing Market Size by Country (2016-2027) 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa Cancer Genome Sequencing Market Size by Country (2016-2027) 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 Cancer Genome Sequencing Market Dynamics 11.1 Cancer Genome Sequencing Industry Trends 11.2 Cancer Genome Sequencing Market Drivers 11.3 Cancer Genome Sequencing Market Challenges 11.4 Cancer Genome Sequencing Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List

List of Tables Table 1. Global Market Cancer Genome Sequencing Market Size (US$ Million) Comparison by Region 2016 VS 2021 VS 2027 Table 2. Global Cancer Genome Sequencing Market Size by Region (2016-2021) & (US$ Million) Table 3. Global Cancer Genome Sequencing Market Size Share by Region (2016-2021) Table 4. Global Cancer Genome Sequencing Forecasted Market Size by Region (2022-2027) & (US$ Million) Table 5. Global Cancer Genome Sequencing Forecasted Market Size Share by Region (2022-2027) Table 6. Global Cancer Genome Sequencing Market Size (US$ Million) by Type: 2016 VS 2021 VS 2027 Table 7. Global Cancer Genome Sequencing Market Size by Type (2016-2021) & (US$ Million) Table 8. Global Cancer Genome Sequencing Revenue Market Share by Type (2016-2021) Table 9. Global Cancer Genome Sequencing Forecasted Market Size by Type (2022-2027) & (US$ Million) Table 10. Global Cancer Genome Sequencing Revenue Market Share by Type (2022-2027) Table 11. Global Cancer Genome Sequencing Market Size (US$ Million) by Application: 2016 VS 2021 VS 2027 Table 12. Global Cancer Genome Sequencing Market Size by Application (2016-2021) & (US$ Million) Table 13. Global Cancer Genome Sequencing Revenue Market Share by Application (2016-2021) Table 14. Global Cancer Genome Sequencing Forecasted Market Size by Application (2022-2027) & (US$ Million) Table 15. Global Cancer Genome Sequencing Revenue Market Share by Application (2022-2027) Table 16. Global Cancer Genome Sequencing Revenue (US$ Million) by Players (2016-2021) Table 17. Global Cancer Genome Sequencing Revenue Market Share by Players (2016-2021) Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cancer Genome Sequencing as of 2020) Table 19. Date of Key Manufacturers Enter into Cancer Genome Sequencing Market Table 20. Global Cancer Genome Sequencing Top Players Headquarters and Area Served Table 21. Cancer Genome Sequencing Product Solution and Service Table 22. Global Cancer Genome Sequencing Players Market Concentration Ratio (CR5 and HHI) Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Agilent Technologies Basic Information List Table 25. Agilent Technologies Description and Business Overview Table 26. Agilent Technologies Cancer Genome Sequencing Products, Services and Solutions Table 27. Revenue (US$ Million) in Cancer Genome Sequencing Business of Agilent Technologies (2016-2021) Table 28. Agilent Technologies Recent Developments Table 29. GE Healthcare Life Sciences Basic Information List Table 30. GE Healthcare Life Sciences Description and Business Overview Table 31. GE Healthcare Life Sciences Cancer Genome Sequencing Products, Services and Solutions Table 32. Revenue (US$ Million) in Cancer Genome Sequencing Business of GE Healthcare Life Sciences (2016-2021) Table 33. GE Healthcare Life Sciences Recent Developments Table 34. Johnson & Johnson Basic Information List Table 35. Johnson & Johnson Description and Business Overview Table 36. Johnson & Johnson Cancer Genome Sequencing Products, Services and Solutions Table 37. Revenue (US$ Million) in Cancer Genome Sequencing Business of Johnson & Johnson (2016-2021) Table 38. Johnson & Johnson Recent Developments Table 39. LI-COR Biosciences Basic Information List Table 40. LI-COR Biosciences Description and Business Overview Table 41. LI-COR Biosciences Cancer Genome Sequencing Products, Services and Solutions Table 42. Revenue (US$ Million) in Cancer Genome Sequencing Business of LI-COR Biosciences (2016-2021) Table 43. LI-COR Biosciences Recent Developments Table 44. Abbott Laboratories Basic Information List Table 45. Abbott Laboratories Description and Business Overview Table 46. Abbott Laboratories Cancer Genome Sequencing Products, Services and Solutions Table 47. Revenue (US$ Million) in Cancer Genome Sequencing Business of Abbott Laboratories (2016-2021) Table 48. Abbott Laboratories Recent Developments Table 49. Beckman Coulter Basic Information List Table 50. Beckman Coulter Description and Business Overview Table 51. Beckman Coulter Cancer Genome Sequencing Products, Services and Solutions Table 52. Revenue (US$ Million) in Cancer Genome Sequencing Business of Beckman Coulter (2016-2021) Table 53. Beckman Coulter Recent Developments Table 54. Bayer Basic Information List Table 55. Bayer Description and Business Overview Table 56. Bayer Cancer Genome Sequencing Products, Services and Solutions Table 57. Revenue (US$ Million) in Cancer Genome Sequencing Business of Bayer (2016-2021) Table 58. Bayer Recent Developments Table 59. Hamilton Thorne Biosciences Basic Information List Table 60. Hamilton Thorne Biosciences Description and Business Overview Table 61. Hamilton Thorne Biosciences Cancer Genome Sequencing Products, Services and Solutions Table 62. Revenue (US$ Million) in Cancer Genome Sequencing Business of Hamilton Thorne Biosciences (2016-2021) Table 63. Hamilton Thorne Biosciences Recent Developments Table 64. Integrated DNA Technologies Basic Information List Table 65. Integrated DNA Technologies Description and Business Overview Table 66. Integrated DNA Technologies Cancer Genome Sequencing Products, Services and Solutions Table 67. Revenue (US$ Million) in Cancer Genome Sequencing Business of Integrated DNA Technologies (2016-2021) Table 68. Integrated DNA Technologies Recent Developments Table 69. Microchip Biotechnologies Basic Information List Table 70. Microchip Biotechnologies Description and Business Overview Table 71. Microchip Biotechnologies Cancer Genome Sequencing Products, Services and Solutions Table 72. Revenue (US$ Million) in Cancer Genome Sequencing Business of Microchip Biotechnologies (2016-2021) Table 73. Microchip Biotechnologies Recent Developments Table 74. Myriad Genetics Basic Information List Table 75. Myriad Genetics Description and Business Overview Table 76. Myriad Genetics Cancer Genome Sequencing Products, Services and Solutions Table 77. Revenue (US$ Million) in Cancer Genome Sequencing Business of Myriad Genetics (2016-2021) Table 78. Myriad Genetics Recent Developments Table 79. Commonwealth Biotechnologies Basic Information List Table 80. Commonwealth Biotechnologies Description and Business Overview Table 81. Commonwealth Biotechnologies Cancer Genome Sequencing Products, Services and Solutions Table 82. Revenue (US$ Million) in Cancer Genome Sequencing Business of Commonwealth Biotechnologies (2016-2021) Table 83. Commonwealth Biotechnologies Recent Developments Table 84. ZS Genetics Basic Information List Table 85. ZS Genetics Description and Business Overview Table 86. ZS Genetics Cancer Genome Sequencing Products, Services and Solutions Table 87. Revenue (US$ Million) in Cancer Genome Sequencing Business of ZS Genetics (2016-2021) Table 88. ZS Genetics Recent Developments Table 89. Pacific Biosciences Basic Information List Table 90. Pacific Biosciences Description and Business Overview Table 91. Pacific Biosciences Cancer Genome Sequencing Products, Services and Solutions Table 92. Revenue (US$ Million) in Cancer Genome Sequencing Business of Pacific Biosciences (2016-2021) Table 93. Pacific Biosciences Recent Developments Table 94. North America Cancer Genome Sequencing Market Size by Country (2016-2021) & (US$ Million) Table 95. North America Cancer Genome Sequencing Market Size by Country (2022-2027) & (US$ Million) Table 96. Europe Cancer Genome Sequencing Market Size by Country (2016-2021) & (US$ Million) Table 97. Europe Cancer Genome Sequencing Market Size by Country (2022-2027) & (US$ Million) Table 98. Asia-Pacific Cancer Genome Sequencing Market Size by Region (2016-2021) & (US$ Million) Table 99. Asia-Pacific Cancer Genome Sequencing Market Size by Region (2022-2027) & (US$ Million) Table 100. Asia-Pacific Cancer Genome Sequencing Market Share by Region (2016-2021) Table 101. Asia-Pacific Cancer Genome Sequencing Market Share by Region (2022-2027) Table 102. Latin America Cancer Genome Sequencing Market Size by Country (2016-2021) & (US$ Million) Table 103. Latin America Cancer Genome Sequencing Market Size by Country (2022-2027) & (US$ Million) Table 104. Middle East & Africa Cancer Genome Sequencing Market Size by Players (2016-2021) & (US$ Million) Table 105. Middle East & Africa Cancer Genome Sequencing Market Size by Country (2022-2027) & (US$ Million) Table 106. Cancer Genome Sequencing Market Trends Table 107. Cancer Genome Sequencing Market Drivers Table 108. Cancer Genome Sequencing Market Challenges Table 109. Cancer Genome Sequencing Market Restraints Table 110. Research Programs/Design for This Report Table 111. Key Data Information from Secondary Sources Table 112. Key Data Information from Primary Sources List of Figures Figure 1. Global Cancer Genome Sequencing Market Size Year-over-Year 2016-2027 & (US$ Million) Figure 2. Global Cancer Genome Sequencing Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 3. Global Cancer Genome Sequencing Market Share by Regions: 2021 VS 2027 Figure 4. Global Cancer Genome Sequencing Forecasted Market Size Share by Region (2022-2027) Figure 5. North America Cancer Genome Sequencing Market Size (US$ Million) Growth Rate (2016-2027) Figure 6. Europe Cancer Genome Sequencing Market Size (US$ Million) and Growth Rate (2016-2027) Figure 7. Asia-Pacific Cancer Genome Sequencing Market Size (US$ Million) and Growth Rate (2016-2027) Figure 8. Latin America Cancer Genome Sequencing Market Size (US$ Million) and Growth Rate (2016-2027) Figure 9. Middle East & Africa Cancer Genome Sequencing Market Size (US$ Million) and Growth Rate (2016-2027) Figure 10. Global Cancer Genome Sequencing Market Size Share by Type in 2021 & 2027 Figure 11. Second Generation Market Size (US$ Million) YoY Growth (2016-2027) Figure 12. Third Generation Market Size (US$ Million) YoY Growth (2016-2027) Figure 13. Global Cancer Genome Sequencing Market Size Share by Application in 2021 & 2027 Figure 14. Treatment Market Size (US$ Million) YoY Growth (2016-2027) Figure 15. Research Market Size (US$ Million) YoY Growth (2016-2027) Figure 16. Cancer Genome Sequencing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 17. Global Top 5 and Top 10 Players Cancer Genome Sequencing Market Share in 2020 Figure 18. North America Cancer Genome Sequencing Market Share by Country (2016-2027) Figure 19. United States Cancer Genome Sequencing Market Size (2016-2027) & (US$ Million) Figure 20. Canada Cancer Genome Sequencing Market Size (2016-2027) & (US$ Million) Figure 21. Germany Cancer Genome Sequencing Market Size (2016-2027) & (US$ Million) Figure 22. France Cancer Genome Sequencing Market Size (2016-2027) & (US$ Million) Figure 23. U.K. Cancer Genome Sequencing Market Size (2016-2027) & (US$ Million) Figure 24. Italy Cancer Genome Sequencing Market Size (2016-2027) & (US$ Million) Figure 25. Russia Cancer Genome Sequencing Market Size (2016-2027) & (US$ Million) Figure 26. Nordic Cancer Genome Sequencing Market Size (2016-2027) & (US$ Million) Figure 27. Rest of Europe Cancer Genome Sequencing Market Size (2016-2027) & (US$ Million) Figure 28. Asia-Pacific Cancer Genome Sequencing Market Share by Region (2016-2027) Figure 29. China Cancer Genome Sequencing Market Size (2016-2027) & (US$ Million) Figure 30. Japan Cancer Genome Sequencing Market Size (2016-2027) & (US$ Million) Figure 31. South Korea Cancer Genome Sequencing Market Size (2016-2027) & (US$ Million) Figure 32. Southeast Asia Cancer Genome Sequencing Market Size (2016-2027) & (US$ Million) Figure 33. India Cancer Genome Sequencing Market Size (2016-2027) & (US$ Million) Figure 34. Australia Cancer Genome Sequencing Market Size (2016-2027) & (US$ Million) Figure 35. Rest of Asia-Pacific Cancer Genome Sequencing Market Size (2016-2027) & (US$ Million) Figure 36. Latin America Cancer Genome Sequencing Market Share by Country (2016-2027) Figure 37. Mexico Cancer Genome Sequencing Market Size (2016-2027) & (US$ Million) Figure 38. Brazil Cancer Genome Sequencing Market Size (2016-2027) & (US$ Million) Figure 39. Rest of Latin America Cancer Genome Sequencing Market Size (2016-2027) & (US$ Million) Figure 40. Middle East & Africa Cancer Genome Sequencing Market Share by Country (2016-2027) Figure 41. Turkey Cancer Genome Sequencing Market Size (2016-2027) & (US$ Million) Figure 42. Saudi Arabia Cancer Genome Sequencing Market Size (2016-2027) & (US$ Million) Figure 43. UAE Cancer Genome Sequencing Market Size (2016-2027) & (US$ Million) Figure 44. Rest of Middle East & Africa Cancer Genome Sequencing Market Size (2016-2027) & (US$ Million) Figure 45. Bottom-up and Top-down Approaches for This Report Figure 46. Data Triangulation

Agilent Technologies GE Healthcare Life Sciences Johnson & Johnson LI-COR Biosciences Abbott Laboratories Beckman Coulter Bayer Hamilton Thorne Biosciences Integrated DNA Technologies Microchip Biotechnologies Myriad Genetics Commonwealth Biotechnologies ZS Genetics Pacific Biosciences